Skip to main content
. 2022 May 4;377:e068723. doi: 10.1136/bmj-2021-068723

Table 1.

Patient characteristics at baseline, treatments, and outcomes. Values are median (interquartile range) unless stated otherwise

Characteristics Estimate (n=7345)
No (%) women 2265 (30.8)
Age (years) 59 (49-68)
SOFA score 4 (3-6)
APACHE II score 14 (10-18)
Ventilation variables at baseline:  
 Tidal volume (mL/kg predicted bodyweight) 6.4 (5.8-7.1)
 FiO2 (%) 60 (49-76)
 Positive end expiratory pressure (cmH2O) 10 (8-12)
 Airway plateau pressure (cmH2O) 22 (20-25)
 Respiratory rate per minute 24 (20-28)
Gas exchange at baseline:  
 PaO2/FiO2 ratio (mm Hg) 130 (88-193)
 PaO2 (mm Hg) 79 (64-100)
 SaO2 (%) 94 (91-96)
 Arterial pH 7.41 (7.35-7.45)
 PaCO2 (mm Hg) 39 (34-47)
 Serum bicarbonate (mmol/L) 24 (22-27)
 Lactate (mmol/L) 1.4 (1.1-1.9)
No (%) of specific treatments recorded for at least one day during follow-up:  
 Prone position 1117 (15.2)
 Neuromuscular blockade agent 1707 (23.2)
 Inhaled nitric oxide 72 (1.0)
 Vasoactive drugs 1590 (21.6)
 Renal replacement therapy 738 (10.0)
 Corticosteroids 2961 (40.3)

SOFA=sequential organ failure assessment; APACHE=acute physiology and chronic health evaluation; FiO2=fraction of inspiratory oxygen; PaO2=arterial partial pressure of oxygen; SaO2=arterial oxygen saturation; PaCO2=arterial partial pressure of carbon dioxide.